Literature DB >> 9853771

A randomised placebo-controlled trial of ursodeoxycholic acid and S-adenosylmethionine in the treatment of intrahepatic cholestasis of pregnancy.

P L Nicastri1, A Diaferia, M Tartagni, P Loizzi, M Fanelli.   

Abstract

A randomised placebo controlled study was performed in 32 women with intrahepatic cholestasis of pregnancy. The population was divided into four groups: for 20 days each group was treated only with ursodeoxycholic acid, or S-adenosylmethionine, or a combination of both drugs, or a placebo (vitamin). Itching, standard liver function tests and serum total bile acids were measured before, during, and after treatment. Itching improved in all the women as well as the biochemical abnormalities. No side-effects in the mother or in the infant were recorded during and after therapy. A combination of ursodeoxycholic acid and S-adenosylmethionine is more effective than placebo and than either drug alone.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9853771     DOI: 10.1111/j.1471-0528.1998.tb09976.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  19 in total

Review 1.  Nonalcoholic fatty liver disease: update on pathogenesis, diagnosis, treatment and the role of S-adenosylmethionine.

Authors:  Mazen Noureddin; José M Mato; Shelly C Lu
Journal:  Exp Biol Med (Maywood)       Date:  2015-04-13

Review 2.  Intrahepatic cholestasis of pregnancy-current achievements and unsolved problems.

Authors:  Jurate Kondrackiene; Limas Kupcinskas
Journal:  World J Gastroenterol       Date:  2008-10-14       Impact factor: 5.742

Review 3.  Intrahepatic cholestasis of pregnancy.

Authors:  Victoria Geenes; Catherine Williamson
Journal:  World J Gastroenterol       Date:  2009-05-07       Impact factor: 5.742

4.  Intrahepatic Cholestasis of Pregnancy.

Authors:  Frank Lammert; Hanns-Ulrich Marschall; Siegfried Matern
Journal:  Curr Treat Options Gastroenterol       Date:  2003-04

Review 5.  The use of selected nutrition supplements and complementary and alternative medicine in liver disease.

Authors:  A James Hanje; Brett Fortune; Ming Song; Daniell Hill; Craig McClain
Journal:  Nutr Clin Pract       Date:  2006-06       Impact factor: 3.080

Review 6.  Interventions for treating cholestasis in pregnancy.

Authors:  Vinita Gurung; Philippa Middleton; Stephen J Milan; William Hague; Jim G Thornton
Journal:  Cochrane Database Syst Rev       Date:  2013-06-24

7.  Is It Necessary to Perform the Pharmacological Interventions for Intrahepatic Cholestasis of Pregnancy? A Bayesian Network Meta-Analysis.

Authors:  Yi Shen; Jie Zhou; Sheng Zhang; Xu-Lin Wang; Yu-Long Jia; Shu He; Yuan-Yuan Wang; Wen-Chao Li; Jian-Guo Shao; Xun Zhuang; Yuan-Lin Liu; Gang Qin
Journal:  Clin Drug Investig       Date:  2019-01       Impact factor: 2.859

8.  The Multiple Facets of ABCB4 (MDR3) Deficiency.

Authors:  Shikha S Sundaram; Ronald J Sokol
Journal:  Curr Treat Options Gastroenterol       Date:  2007-12

9.  Ursodeoxycholic acid versus placebo, and early term delivery versus expectant management, in women with intrahepatic cholestasis of pregnancy: semifactorial randomised clinical trial.

Authors:  Lucy C Chappell; Vinita Gurung; Paul T Seed; Jenny Chambers; Catherine Williamson; James G Thornton
Journal:  BMJ       Date:  2012-06-13

10.  Pilot study for a trial of ursodeoxycholic acid and/or early delivery for obstetric cholestasis.

Authors:  Vinita Gurung; Catherine Williamson; Lucy Chappell; Jenny Chambers; Annette Briley; Fiona Broughton Pipkin; Jim Thornton
Journal:  BMC Pregnancy Childbirth       Date:  2009-05-16       Impact factor: 3.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.